188 related articles for article (PubMed ID: 22130733)
1. Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B.
Diezi TA; Kwon G
Pharm Res; 2012 Jul; 29(7):1737-44. PubMed ID: 22130733
[TBL] [Abstract][Full Text] [Related]
2. Susceptibilities of phospholipid vesicles containing different sterols to amphotericin B-loaded lysophosphatidylcholine micelles.
Onda M; Inoue Y; Kawabata M; Mita T
J Biochem; 2003 Jul; 134(1):121-8. PubMed ID: 12944378
[TBL] [Abstract][Full Text] [Related]
3. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
Alvarez C; Shin DH; Kwon GS
Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
[TBL] [Abstract][Full Text] [Related]
4. Small-angle neutron scattering studies of the effects of amphotericin B on phospholipid and phospholipid-sterol membrane structure.
Foglia F; Drake AF; Terry AE; Rogers SE; Lawrence MJ; Barlow DJ
Biochim Biophys Acta; 2011 Jun; 1808(6):1574-80. PubMed ID: 21334304
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.
Yu BG; Okano T; Kataoka K; Sardari S; Kwon GS
J Control Release; 1998 Dec; 56(1-3):285-91. PubMed ID: 9801451
[TBL] [Abstract][Full Text] [Related]
7. Effect of aggregation of amphotericin B on lysophosphatidylcholine micelles as related to its complex formation with cholesterol or ergosterol.
Kawabata M; Onda M; Mita T
J Biochem; 2001 May; 129(5):725-32. PubMed ID: 11328594
[TBL] [Abstract][Full Text] [Related]
8. Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B.
Thanki K; Prajapati R; Sangamwar AT; Jain S
Int J Pharm; 2018 Jun; 544(1):1-13. PubMed ID: 29635057
[TBL] [Abstract][Full Text] [Related]
9. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.
Yu BG; Okano T; Kataoka K; Kwon G
J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920
[TBL] [Abstract][Full Text] [Related]
10. The effect of aggregation state of amphotericin-B on its interactions with cholesterol- or ergosterol-containing phosphatidylcholine monolayers.
Barwicz J; Tancrède P
Chem Phys Lipids; 1997 Feb; 85(2):145-55. PubMed ID: 9138890
[TBL] [Abstract][Full Text] [Related]
11. Interaction of amphotericin B and saturated or unsaturated phospholipid monolayers containing cholesterol or ergosterol at the air-water interface.
Wang J; Ma Y; Hou S; Miao Z; Ma Q
Biophys Chem; 2020 Mar; 258():106317. PubMed ID: 31918025
[TBL] [Abstract][Full Text] [Related]
12. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets.
Neumann A; Baginski M; Czub J
J Am Chem Soc; 2010 Dec; 132(51):18266-72. PubMed ID: 21126070
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
Adams ML; Andes DR; Kwon GS
Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
[TBL] [Abstract][Full Text] [Related]
14. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
15. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length.
Adams ML; Kwon GS
J Control Release; 2003 Feb; 87(1-3):23-32. PubMed ID: 12618020
[TBL] [Abstract][Full Text] [Related]
16. Linolenic acid-modified MPEG-PEI micelles for encapsulation of amphotericin B.
Xu H; Teng F; Zhou F; Zhu L; Wen Y; Feng R; Song Z
Future Med Chem; 2019 Oct; 11(20):2647-2662. PubMed ID: 31621420
[No Abstract] [Full Text] [Related]
17. Ion channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy.
Huang W; Zhang Z; Han X; Tang J; Wang J; Dong S; Wang E
Biophys J; 2002 Dec; 83(6):3245-55. PubMed ID: 12496093
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
[TBL] [Abstract][Full Text] [Related]
19. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.
Luengo-Alonso C; Torrado JJ; Ballesteros MP; Malfanti A; Bersani S; Salmaso S; Caliceti P
Int J Pharm; 2015 Nov; 495(1):41-51. PubMed ID: 26319629
[TBL] [Abstract][Full Text] [Related]
20. The structuring effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers: a differential scanning calorimetry study.
Fournier I; Barwicz J; Tancrède P
Biochim Biophys Acta; 1998 Aug; 1373(1):76-86. PubMed ID: 9733926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
